We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+3.52%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.17B
AUM Growth
+$22.1M
Cap. Flow
-$7.06M
Cap. Flow %
-0.6%
Top 10 Hldgs %
42.82%
Holding
206
New
10
Increased
100
Reduced
48
Closed
6

Top Buys

Rank Stock Value
1
PPL
PPL Corp
PPL
+$2.74M
2
AAPL icon
Apple
AAPL
+$2.56M
3
UPS icon
United Parcel Service
UPS
+$1.87M
4
WMT icon
Walmart Inc
WMT
+$1.84M
5
CRM icon
Salesforce
CRM
+$1.66M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$31.7M
2
KHC icon
Kraft Heinz
KHC
+$4.2M
3
PAYX icon
Paychex
PAYX
+$4M
4
SYY icon
Sysco
SYY
+$3.68M
5
META icon
Meta Platforms (Facebook)
META
+$2.47M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.66%
2 Healthcare 13.73%
3 Financials 10.29%
4 Technology 9.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
51
JD.com
JD
$41.6B
$6.09M 0.52%
230,000
+50,000
+28% +$1.31M
T icon
52
AT&T
T
$167B
$6.02M 0.51%
203,626
+265
+0.1% +$7.34K
OXY icon
53
Occidental Petroleum
OXY
$55.1B
$6.02M 0.51%
88,000
+20,435
+30% +$1.37M
MO icon
54
Altria Group
MO
$122B
$5.96M 0.51%
95,100
+26,300
+38% +$1.59M
VMC icon
55
Vulcan Materials
VMC
$36.9B
$5.95M 0.51%
56,323
CVS icon
56
CVS Health
CVS
$137B
$5.72M 0.49%
55,180
+1,000
+2% +$97.2K
ABBV icon
57
AbbVie
ABBV
$457B
$5.64M 0.48%
98,750
+12,400
+14% +$691K
RTX icon
58
RTX Corp
RTX
$297B
$5.53M 0.47%
87,849
+4,131
+5% +$240K
JCI icon
59
Johnson Controls International
JCI
$86.4B
$5.31M 0.45%
130,071
+36,195
+39% +$1.38M
CME icon
60
CME Group
CME
$92.2B
$5.26M 0.45%
54,800
-170
-0.3% -$15.5K
YUM icon
61
Yum! Brands
YUM
$41B
$5.23M 0.45%
88,913
+557
+0.6% +$29.2K
MA icon
62
Mastercard
MA
$488B
$5.17M 0.44%
54,660
+4,100
+8% +$363K
IBM icon
63
IBM
IBM
$205B
$5.16M 0.44%
35,619
-2,194
-6% -$280K
AEP icon
64
American Electric Power
AEP
$72.8B
$5.13M 0.44%
77,300
-10,500
-12% -$649K
ADP icon
65
Automatic Data Processing
ADP
$103B
$5.11M 0.44%
56,905
+4,500
+9% +$377K
BP icon
66
BP
BP
$110B
$5.09M 0.43%
200,452
+12,123
+6% +$306K
CELG
67
DELISTED
Celgene Corp
CELG
$5.03M 0.43%
50,207
+800
+2% +$82.4K
LHX icon
68
L3Harris
LHX
$56.5B
$4.92M 0.42%
63,200
+7,500
+13% +$600K
ADBE icon
69
Adobe
ADBE
$96.1B
$4.91M 0.42%
52,360
+1,280
+3% +$111K
DHR icon
70
Danaher
DHR
$137B
$4.88M 0.42%
76,512
+1,786
+2% +$106K
GILD icon
71
Gilead Sciences
GILD
$163B
$4.59M 0.39%
49,922
+12,390
+33% +$1.12M
ESRX
72
DELISTED
Express Scripts Holding Company
ESRX
$4.52M 0.39%
65,780
TGT icon
73
Target
TGT
$63.8B
$4.32M 0.37%
52,500
+19,300
+58% +$1.46M
UNP icon
74
Union Pacific
UNP
$177B
$4.29M 0.37%
53,890
+13,300
+33% +$1.03M
PSX icon
75
Phillips 66
PSX
$83.3B
$4.28M 0.37%
49,400
+8,400
+20% +$683K

Similar funds

Cullinan Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Cullinan Associates held 206 positions worth $1.17B, up 1.9% from $1.15B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q1 2016 filing shows 10 new, 100 increased, 48 reduced and 6 closed positions. Its largest new stake was PPL Corp: 77,150 shares worth $2.94M. The largest sale was Bristol-Myers Squibb, an estimated $31.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q1 2016 buy was PPL Corp: 77,150 shares worth $2.94M.
  • Cullinan Associates added most to Apple in Q1 2016, an estimated $2.56M increase.
  • Cullinan Associates's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $31.7M.
  • Cullinan Associates fully exited Kraft Heinz in Q1 2016, selling an estimated $4.2M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.17B portfolio in Q1 2016.
  • Cullinan Associates opened 10 new positions and closed 6 in Q1 2016.
  • Cullinan Associates's portfolio value rose 1.9% quarter-over-quarter to $1.17B.

Based on Cullinan Associates's 13F filing for Q1 2016, filed 20 May 2016.